42.23
전일 마감가:
$41.59
열려 있는:
$41.88
하루 거래량:
854.67K
Relative Volume:
0.48
시가총액:
$7.76B
수익:
$520.18M
순이익/손실:
$-348.13M
주가수익비율:
-21.99
EPS:
-1.92
순현금흐름:
$-176.18M
1주 성능:
+7.07%
1개월 성능:
+24.21%
6개월 성능:
+21.81%
1년 성능:
-28.11%
Legend Biotech Corp Adr Stock (LEGN) Company Profile
LEGN을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
LEGN
Legend Biotech Corp Adr
|
42.23 | 7.26B | 520.18M | -348.13M | -176.18M | -1.92 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Legend Biotech Corp Adr Stock (LEGN) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-10-08 | 개시 | Redburn Atlantic | Buy |
2024-06-17 | 개시 | Truist | Buy |
2024-05-24 | 재확인 | H.C. Wainwright | Buy |
2024-05-23 | 개시 | Deutsche Bank | Buy |
2024-04-17 | 업그레이드 | Scotiabank | Sector Perform → Sector Outperform |
2024-04-03 | 개시 | Cantor Fitzgerald | Overweight |
2024-03-13 | 개시 | Raymond James | Outperform |
2023-12-19 | 개시 | Scotiabank | Sector Perform |
2023-11-06 | 개시 | Goldman | Buy |
2023-05-25 | 개시 | William Blair | Mkt Perform |
2023-05-22 | 개시 | Daiwa Securities | Buy |
2023-03-29 | 개시 | H.C. Wainwright | Buy |
2023-03-24 | 개시 | RBC Capital Mkts | Outperform |
2022-12-06 | 개시 | UBS | Buy |
2022-11-02 | 개시 | Evercore ISI | Outperform |
2022-11-01 | 개시 | Cowen | Outperform |
2022-10-31 | 개시 | Guggenheim | Neutral |
2022-06-17 | 개시 | BMO Capital Markets | Outperform |
2022-03-15 | 개시 | Barclays | Overweight |
2022-01-31 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
2022-01-06 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2021-12-21 | 개시 | Piper Sandler | Overweight |
2021-05-18 | 개시 | BTIG Research | Buy |
2020-07-01 | 개시 | JP Morgan | Overweight |
2020-07-01 | 개시 | Jefferies | Buy |
2020-06-30 | 개시 | Morgan Stanley | Overweight |
모두보기
Legend Biotech Corp Adr 주식(LEGN)의 최신 뉴스
HC Wainwright Forecasts Legend Biotech Q2 Earnings - Defense World
Legend Biotech’s (LEGN) Buy Rating Reiterated at HC Wainwright - Defense World
Q1 EPS Estimates for Legend Biotech Raised by HC Wainwright - Defense World
Legend Biotech (LEGN) Surges 6.0%: Is This an Indication of Further Gains? - Yahoo Finance
Legend Biotech’s SWOT analysis: stock poised for growth amid challenges - Investing.com India
H.C. Wainwright reiterates Buy rating on Legend Biotech stock after strong CARVYKTI sales - Investing.com India
Goldman Sachs reiterates buy rating on Legend Biotech stock after strong Carvykti sales - Investing.com
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Shares Acquired by GAMMA Investing LLC - Defense World
Legend Biotech stock price target lowered to $54 at UBS on growth concerns - Investing.com
Legend Biotech stock maintains Buy rating as FDA eases CARVYKTI restrictions - Investing.com
Legend Biotech’s SWOT analysis: carvykti’s strong performance drives stock potential By Investing.com - Investing.com South Africa
Legend Biotech’s SWOT analysis: carvykti’s strong performance drives stock potential - Investing.com India
Legend Biotech to Host Investor Event During the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting - Barchart.com
Oracle and GameStop Headline Market Cap Stock Movers on Thursday By Investing.com - Investing.com South Africa
Eli Lilly, General Electric among Tuesday’s market cap stock movers By Investing.com - Investing.com India
Eli Lilly, General Electric among Tuesday’s market cap stock movers - Investing.com
CARVYKTI shows lasting impact in multiple myeloma treatment By Investing.com - Investing.com South Africa
RBC Capital maintains outperform rating on Legend Biotech stock By Investing.com - Investing.com South Africa
RBC Capital maintains outperform rating on Legend Biotech stock - Investing.com India
BMO Capital reaffirms outperform rating on Legend Biotech stock By Investing.com - Investing.com South Africa
BMO Capital reaffirms outperform rating on Legend Biotech stock - Investing.com India
Legend Biotech’s SWOT analysis: carvykti drives growth as stock faces competition - Investing.com India
RBC Capital maintains Legend Biotech at outperform with $78 target By Investing.com - Investing.com South Africa
RBC Capital maintains Legend Biotech at outperform with $78 target - Investing.com
AbbVie, Nvidia, and Exelixis Lead Market Cap Stock Movers on Wednesday By Investing.com - Investing.com South Africa
AbbVie, Nvidia, and Exelixis Lead Market Cap Stock Movers on Wednesday - Investing.com
Legend Biotech stock holds $62 target, solid Carvykti sales growth - Investing.com India
Legend Biotech stock holds $62 target, solid Carvykti sales growth By Investing.com - Investing.com UK
Truist cuts Legend Biotech stock target to $71, maintains buy rating - Investing.com India
Raymond James maintains Legend Biotech Outperform rating - Investing.com
Raymond James maintains Legend Biotech Outperform rating By Investing.com - Investing.com UK
Earnings call transcript: Legend Biotech Q1 2025 sees strong CARVICTI sales boost - Investing.com India
Legend Biotech Q1 2025 slides: CARVYKTI sales surge 135% as path to profitability clarifies - Investing.com India
Legend Biotech Reports First Quarter 2025 Results and Recent Highlights - GlobeNewswire Inc.
Stock Surge: Legend Biotech Corp ADR (LEGN) Closes at 31.37, Marking a -6.08 Increase/Decrease - DWinneX
What Makes Legend Biotech (LEGN) a New Buy Stock - Yahoo Finance
Wall Street Analysts Think Legend Biotech (LEGN) Could Surge 135.16%: Read This Before Placing a Bet - Yahoo Finance
Top investors say Legend Biotech Corp ADR (LEGN) ticks everything they need - Sete News
LEGN stock rated a Buy by Redburn Atlantic - knoxdaily.com
Taking a look at what insiders are doing to gauge the Legend Biotech Corp ADR (LEGN)’s direction - knoxdaily.com
Selling Buzz: Graphjet Technology [GTI] 10% Owner SURIA SUKSES ENGINEERING SDN B sells 2,490,517 shares of the company – Knox Daily - knoxdaily.com
UP Fintech Holding Ltd ADR [TIGR] Records 200-Day SMA of $6.22 - knoxdaily.com
UEC Stock Sees Surge of Approximately 9.34% in Last Five Days - knoxdaily.com
Vir Biotechnology Inc [VIR] Records 200-Day SMA of $8.24 - knoxdaily.com
Arm Holdings plc. ADR [ARM] Officer makes an insider purchase of 9,220 shares worth 1.41 million. - knoxdaily.com
Valero Energy Corp [VLO] Records 200-Day SMA of $134.80 - knoxdaily.com
KE Holdings Inc ADR [BEKE] Records 200-Day SMA of $18.54 - knoxdaily.com
Celestica, Inc [NYSE: CLS] Sees Increase in Stock Value - knoxdaily.com
Perimeter Solutions Inc [PRM] Records 50-Day SMA of $9.97 - knoxdaily.com
JBI Shares Experience Surge in Value - knoxdaily.com
CRGY Shares Experience Surge in Value - knoxdaily.com
Legend Biotech Corp Adr (LEGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):